|
1
|
Castleberry RP, Pritchard J, Ambros P, et
al: The International Neuroblastoma Risk Groups (INRG): a
preliminary report. Eur J Cancer. 33:2113–2116. 1997. View Article : Google Scholar
|
|
2
|
Li T, Wang L, Ke XX, et al: DNA-damaging
drug-induced apoptosis sensitized by N-myc in neuroblastoma cells.
Cell Biol Int. 36:331–337. 2012. View Article : Google Scholar
|
|
3
|
Shimada H, Ambros IM, Dehner LP, et al:
The International Neuroblastoma Pathology Classification (the
Shimada system). Cancer. 86:364–372. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brodeur GM: Neuroblastoma: biological
insights into a clinical enigma. Nat Rev Cancer. 3:203–216. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cui H, Ma J, Ding J, et al: Bmi-1
regulates the differentiation and clonogenic self-renewal of I-type
neuroblastoma cells in a concentration-dependent manner. J Biol
Chem. 281:34696–34704. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheung NK and Dyer MA: Neuroblastoma:
developmental biology, cancer genomics and immunotherapy. Nat Rev
Cancer. 13:397–411. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morgenstern DA, Baruchel S and Irwin MS:
Current and future strategies for relapsed neuroblastoma:
challenges on the road to precision therapy. J Pediatr Hematol
Oncol. 35:337–347. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Camirand A, Fadhil I, Luco AL, et al:
Enhancement of taxol, doxorubicin and zoledronate
anti-proliferation action on triple-negative breast cancer cells by
a PTHrP blocking monoclonal antibody. Am J Cancer Res. 3:500–508.
2013.PubMed/NCBI
|
|
9
|
Jia L, Ma S, Hou X, et al: The synergistic
effects of traditional Chinese herbs and radiotherapy for cancer
treatment. Oncol Lett. 5:1439–1447. 2013.PubMed/NCBI
|
|
10
|
Kavandi L, Lee LR, Bokhari AA, et al: The
Chinese herbs Scutellaria baicalensis and Fritillaria cirrhosa
target NFκB to inhibit proliferation of ovarian and endometrial
cancer cells. Mol Carcinog. 2013. View
Article : Google Scholar
|
|
11
|
Hailong G, Yujie Z, Hanying M, et al:
Effectiveness of triptolide-coated stent on decreasing inflammation
and attenuation of intimal hyperplasia in a pig after coronary
angioplasty. Angiology. 62:265–269. 2011. View Article : Google Scholar
|
|
12
|
Wu R, Li Y, Guo Z, et al: Triptolide
ameliorates ileocolonic anastomosis inflammation in IL-10 deficient
mice by mechanism involving suppression of miR-155/SHIP-1 signaling
pathway. Mol Immunol. 56:340–346. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Owa C, Messina ME Jr and Halaby R:
Triptolide induces lysosomal-mediated programmed cell death in
MCF-7 breast cancer cells. Int J Womens Health. 5:557–569.
2013.PubMed/NCBI
|
|
14
|
Banerjee S, Sangwan V, McGinn O, et al:
Triptolide-induced cell death in pancreatic cancer is mediated by
O-GlcNAc modification of transcription factor Sp1. J Biol Chem.
288:33927–33938. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chueh FS, Chen YL, Hsu SC, et al:
Triptolide induced DNA damage in A375.S2 human malignant melanoma
cells is mediated via reduction of DNA repair genes. Oncol Rep.
29:613–618. 2013.
|
|
16
|
Chen YW, Lin GJ, Hueng DY, et al: Enhanced
anti-tumor activity of triptolide in combination with irradiation
for the treatment of oral cancer. Planta Med. 80:255–261. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang XF, Zhao YB, Wu Q, et al: Triptolide
induces apoptosis in endometrial cancer via a p53-independent
mitochondrial pathway. Mol Med Rep. 9:39–44. 2014.
|
|
18
|
Krizanova O, Markova J, Pacak K, et al:
Triptolide induces apoptosis through the SERCA 3 upregulation in
PC12 cells. Gen Physiol Biophys. 33:137–144. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Johnson SM, Wang X and Evers BM:
Triptolide inhibits proliferation and migration of colon cancer
cells by inhibition of cell cycle regulators and cytokine
receptors. J Surg Res. 168:197–205. 2011. View Article : Google Scholar
|
|
20
|
Ma JX, Sun YL, Wang YQ, et al: Triptolide
induces apoptosis and inhibits the growth and angiogenesis of human
pancreatic cancer cells by downregulating COX-2 and VEGF. Oncol
Res. 20:359–368. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Antonoff MB, Chugh R, Borja-Cacho D, et
al: Triptolide therapy for neuroblastoma decreases cell viability
in vitro and inhibits tumor growth in vivo. Surgery. 146:282–290.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wan YG, Che XY, Sun W, et al: Low-dose of
multi-glycoside of Tripterygium wilfordii Hook. f., a natural
regulator of TGF-β1/Smad signaling activity improves
adriamycin-induced glomerulosclerosis in vivo. J Ethnopharmacol.
151:1079–1089. 2014. View Article : Google Scholar
|
|
23
|
Ge Y, Xie H, Li S, et al: Treatment of
diabetic nephropathy with Tripterygium wilfordii Hook F extract: a
prospective, randomized, controlled clinical trial. J Transl Med.
11:1342013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen Y, Gong Z, Chen X, et al:
Tripterygium wilfordii Hook F (a traditional Chinese medicine) for
primary nephrotic syndrome. Cochrane Database Syst Rev.
8:CD0085682013.PubMed/NCBI
|
|
25
|
Helmstädter A: Tripterygium wilfordii
Hook. f. - how a traditional Taiwanese medicinal plant found its
way to the West. Pharmazie. 68:643–646. 2013.PubMed/NCBI
|
|
26
|
Huang W, He T, Chai C, et al: Triptolide
inhibits the proliferation of prostate cancer cells and
down-regulates SUMO-specific protease 1 expression. PLoS One.
7:e376932012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Z, Ma L, Wen ZS, et al: Cancerous
inhibitor of PP2A is targeted by natural compound celastrol for
degradation in non-small-cell lung cancer. Carcinogenesis.
35:905–914. 2014. View Article : Google Scholar
|
